Stay updated on Pembrolizumab Combo for Melanoma Brain Metastasis Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combo for Melanoma Brain Metastasis Clinical Trial page.

Latest updates to the Pembrolizumab Combo for Melanoma Brain Metastasis Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoChange DetectedA new study-record version dated 2026-10-05 was added, covering study status, arms and interventions, outcome measures, and results sections including participant flow, baseline characteristics, and adverse events. The record also indicates that quality control review has not concluded and was returned on 2026-10-28.SummaryDifference0.7%

- Check14 days agoChange DetectedA site-wide NIH notice announces a transition in terminology from “Artificial Intelligence” to “Super Intelligence” and links to related updates and FAQs.SummaryDifference0.3%

- Check21 days agoChange DetectedThe site footer revision identifier changed from v3.7.1 to v3.7.2.SummaryDifference0.0%

- Check28 days agoChange DetectedThe study record now indicates that results have been submitted, replacing the previous “No Results Posted” status.SummaryDifference0.1%

- Check49 days agoChange DetectedA new revision entry (v3.7.0) was added to the history and the previous revision (v3.6.6) was removed, indicating a page version update in the study history records.SummaryDifference0.0%

- Check70 days agoChange DetectedThe footer now shows Revision: v3.6.6, replacing the previous v3.6.5, indicating a small internal update to the page's versioning.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab Combo for Melanoma Brain Metastasis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo for Melanoma Brain Metastasis Clinical Trial page.